Merck Animal Health Announces 2020 High-Quality Pork — Precision Farming Award Recipient
Winner Granted Funds to Implement Applied Project in Precision Farming in Swine
Newsroom
Merck Animal Health Announces Leadership in Newly Formed Animal Health Intelligence Operating Unit
Merck Animal Health, known as MSD Animal Health outside the United States and Canada, a division of Merck & Co., Inc., Kenilworth, N.J., USA (NYSE:MRK), today announced Jeroen van de Ven, DVM, MBA, as the leader of Merck Animal Health Intelligence, a newly formed, specialized operating unit which takes its name from the company’s strategic vision for animal health intelligence and data expertise.
Merck Animal Health Supports Rabies Elimination by 2030 on World Rabies Day
Campaign raises awareness about importance of dog vaccination MADISON, N.J., Sept. 28, 2020 – In recognition of World Rabies Day on September 28, Merck Animal Health, known as MSD Animal Health outside the United States and Canada, a division of Merck & Co., Inc., Kenilworth, N.J., USA (NYSE:MRK), today announced the launch of a global campaign […]
Sure Petcare Showcases Pet Technology at Expo in Bay of Plenty
AUCKLAND, NZ, (Sept. 22, 2020) –Sure Petcare, the leading pet technology specialist, will debut its latest in pet technology, the SUREFEED® Microchip Pet Feeder Connect and ANIMO® dog behaviour and activity monitor, at the Pet & Animal Expo held at the Bay Park, Mt Maunganui on 3 and 4th October 2020. Additionally, visitors also will […]
Merck Animal Health Announces Call for Submissions for New High-Quality Pork—Precision Farming Award
Winner to Be Awarded Up to $200,000 Towards Project Implementation
Merck Animal Health Completes Acquisition of IdentiGEN
Strategic Transaction Enhances Farm-to-Table Animal Traceability Solutions for Livestock and Aquaculture
Merck Animal Health Completes Acquisition of Worldwide Rights to VECOXAN® Brand of Parasiticides for Ruminant Portfolio
Broadens Merck Animal Health’s Position with Enhanced Parasite Protection in Calves and Lambs
Merck Animal Health Receives U.S. FDA Approval of BRAVECTO® (fluralaner) Monthly Chews
Portfolio Expansion Ensures Dogs and Puppies 8 Weeks of Age and Older Receive Early, Broad-Spectrum Protection Against Fleas and Ticks About BRAVECTO® (fluralaner) Since its introduction in 2014, BRAVECTO has provided longer-lasting flea and tick protection with more than 125 million doses distributed in 85 countries. BRAVECTO is available in a variety of extended-duration formulations, […]
Merck Animal Health Completes Acquisition of U.S. Rights to SENTINEL® Brand of Combination Parasiticides for Companion Animals
Further Solidifies Merck Animal Health’s Position in the U.S. Companion Animal Category with Comprehensive, Continuous Parasite Protection
Merck Animal Health Announces $100 Million Investment in its DeSoto, Kansas, Manufacturing Operations
Facility Expansion and Enhancement Efforts Build Strength for the Future to Better Meet Customer Demand